Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Stallergenes Greer
Biotech
Stallergenes' allergy immunotherapy hits goal in phase 3
The late-phase success sets Stallergenes up to file for FDA approval of oral immunotherapy STAGR320.
Nick Paul Taylor
Nov 20, 2018 9:00am
Stallergenes, Stanford pen allergy immunotherapy pact
Nov 14, 2016 5:51am
Stallergenes Greer poaches Zoetis IT exec following manufacturing mixup
Apr 15, 2016 2:32am
